Skip to content. | Skip to navigation

Personal tools

Navigation path

SEURAT-1 Research Initiative - Annual Meeting 2011

Event details
Feb 08, 2012 08:30 AM to
Feb 09, 2012 05:30 PM
Lisbon (Portugal)
Organizer: SEURAT-1 Cluster

SEURAT ('Safety Evaluation Ultimately Replacing Animal Testing') pushes for a fundamental change in the way we assess the safety of chemicals

The SEURAT-1 Research Initiative will have its second Annual Meeting on 8 and 9 February 2012 in Lisbon, Portugal. The meeting is co-organised by the Joint Research Centre, Institute for Health and Consumer Protection (JRC-IHCP), which contributed to formulate and implement the SEURAT-1 vision and research strategy, pushing for a fundamental change in the way we assess the safety of chemicals (SEURAT: 'Safety Evaluation Ultimately Replacing Animal Testing').

Download the final programme of the event.

This second annual event will give the partners of the SEURAT-1 cluster the opportunity to get informed about the projects achievements over the last year, take part to scientific focused sessions and attend panel discussions in the presence of renowned experts.

On 8 February Maurice Whelan, Head of the Systems Toxicology Unit (JRC-IHCP) and member of SEURAT-1 COACH project, will present the SEURAT-1 vision and strategy.

The JRC-IHCP manages the general coordination project of the cluster (COACH), intended to facilitate synergies between projects and partners, and is heavily involved in three of the five complementary research projects, contributing to several key research areas (development and standardisation of reliable stem cell differentiation protocols; computational prediction tools for determining the fate of a chemical within the body after exposure, and for modelling the reaction of cells to a toxic insult; discovery of new biomarkers at the molecular and cellular level for detecting early toxicological events; high throughput robotic testing to generate high quality datasets using novel in vitro assays; selection of reference chemicals with known toxicological profiles for use in test system development and evaluation; extension of TTC (Thresholds of Toxicological Concern) safety assessment frameworks to include cosmetic ingredients).

Having kicked off on 1 January 2011, with a total budget of EUR 50 million, SEURAT-1 (the first phase of the SEURAT strategy) will last for 5 years, co-financed by the European Commission’s Directorate General for Research and Innovation, within the HEALTH theme of the Seventh Framework Programme (FP7), and the European Cosmetics Association (Colipa). The JRC-IHCP is also committing significant resources through its own institutional funding and work programme.
In October 2011 SEURAT-1 delivered its Annual Report 2011 (first out of six): "Towards the replacement of in vivo repeated dose systemic toxicity testing".
Successful completion of SEURAT-1 will lay the foundation for follow-on efforts in SEURAT-2 that will broaden the toxicological, chemical, and regulatory domains addressed.